Trials / Completed
CompletedNCT00451750
Cortisol in the Treatment of Phobias
The Efficacy of Cortisol in Combination With Behavioral Therapy in the Treatment of Phobias
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cortisol | 20 mg for 3 times |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2007-03-23
- Last updated
- 2010-01-12
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00451750. Inclusion in this directory is not an endorsement.